NT-ProBNP (N-Terminal Pro B-Type Natriuretic Peptide)*

Analyte: N-terminal ProB-type Natriuretic Peptide
Specimen Type: Serum, Heparin Plasma, EDTA Plasma
Optimum Volume: 0.5 mL.
Reporting Units: pg/mL
Method: Electrochemiluminescence
2-8°C 6 days
-20°C 2 years
-70°C 2 years

Biological or Clinical Significance:

The clinical utility of CNH assays for B-type natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) has been confirmed for screening of heart disease, stratification of patients with congestive heart failure, detection of left ventricular systolic and/or diastolic dysfunction, and differential diagnosis of dyspnea.

Principle of Test Method:

The NT-ProBNP assay is an automated electrochemiluminescent assay.